Sunil Kumar, MD
Clinical Cardiac Electrophysiology · Kissimmee, FLNPI 1407184377
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $103,700 of the $164,983 with a category attached, or 62.9%. 23 manufacturers reported payments, led by Medical Device Business Services, Inc. at 51.4% of the total. Reporting peaked in 2024 at $39,351 and has fallen 76.4% since, to $9,279 in 2025. Among clinical cardiac electrophysiology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 315 payments — averaging $523.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$85K
- Medtronic$60K
- Abbott$6K
- Biosense Webster, Inc.$5K
- Altathera Pharmaceuticals LLC$4K
- Biotronik Inc.$1K
- plus $4K from 17 others
What the payments were for
- Consulting fees$103,70063%
- Speaking & faculty fees$47,80029%
- Travel & lodging$3,7922%
- Food & beverage$9,4406%
- Education$2520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 54 | $84,750 |
| Medtronic(2 entities) | 85 | $60,015 |
| Abbott | 42 | $5,868 |
| Biosense Webster, Inc. | 40 | $5,228 |
| Altathera Pharmaceuticals LLC | 5 | $4,278 |
| Biotronik Inc. | 2 | $1,200 |
| Impulse Dynamics (USA) Inc. | 17 | $705 |
| Boston Scientific | 11 | $658 |
| Cvrx, Inc. | 10 | $494 |
| Terumo Medical Corporation | 1 | $350 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $334 |
| Abiomed | 2 | $284 |
| Pfizer | 11 | $254 |
| AstraZeneca | 5 | $111 |
| Astellas Pharma US Inc | 1 | $100 |
| Novartis | 4 | $76 |
| Johnson & Johnson | 4 | $73 |
| Cardiva Medical, Inc. | 1 | $67 |
| Merck | 3 | $61 |
| Boehringer Ingelheim | 1 | $24 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Portola Pharmaceuticals, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$74,880
- Carto 3 System$13,300
- Sotalol Hydrochloride$4,278
- Micra$2,568
- AMPLATZER AMULET$2,232
- Sentus$1,200
- Plexa$1,200
- Rivacor$1,200
- Edora$1,200
- Acticor$1,200
- AVEIR$985
- AMPLATZER$984
- Thermocool$932
- AZURE XT DR MRI SURESCAN$626
- OPTIMIZER$555
- Barostim Neo System$389
- Confirm Rx$350
- Watchman$278
- CG Future$173
- AFFERA MAPPING SYSTEM$158
How this compares
$164,983 in reported general payments places this provider in the 90th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 245 | $275,648 |
| JardianceEmpagliflozin | 80 | $111,974 |
| EntrestoSacubitril/Valsartan | 70 | $96,788 |
| XareltoRivaroxaban | 47 | $68,676 |
| FarxigaDapagliflozin Propanediol | 14 | $16,582 |
| Dofetilide | 46 | $4,665 |
| Flecainide Acetate | 91 | $3,367 |
| Metoprolol Succinate | 248 | $3,357 |
| Torsemide | 113 | $2,013 |
| Amiodarone Hcl | 104 | $1,980 |
| Carvedilol | 187 | $1,612 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 40 | $1,098 |
| Spironolactone | 76 | $1,037 |
| Potassium Chloride | 35 | $1,009 |
| Losartan Potassium | 77 | $992 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $254 | $275,648245 claims |
| Boehringer IngelheimJardiance | $24 | $111,97480 claims |
| NovartisEntresto | $76 | $96,78870 claims |
| Johnson & JohnsonXarelto | $73 | $68,67647 claims |
| AstraZenecaFarxiga | $111 | $16,58214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Kissimmee
- Naushad ShaikKissimmee$691K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
- Marcelo JimenezAtlantis$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.